State Street’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.9K | Sell |
67,145
-165,406
| -71% | -$197K | ﹤0.01% | 4016 |
|
|
2025
Q1 | $472K | Sell |
232,551
-4,050
| -2% | -$8.22K | ﹤0.01% | 3605 |
|
|
2024
Q4 | $1.42M | Buy |
236,601
+10,705
| +5% | +$64.4K | ﹤0.01% | 3408 |
|
|
2024
Q3 | $1.58M | Buy |
225,896
+47,233
| +26% | +$331K | ﹤0.01% | 3396 |
|
|
2024
Q2 | $1.04M | Buy |
178,663
+45,387
| +34% | +$263K | ﹤0.01% | 3469 |
|
|
2024
Q1 | $953K | Hold |
133,276
| – | – | ﹤0.01% | 3483 |
|
|
2023
Q4 | $656K | Hold |
133,276
| – | – | ﹤0.01% | 3580 |
|
|
2023
Q3 | $1.27M | Buy |
133,276
+7,300
| +6% | +$69.8K | ﹤0.01% | 3464 |
|
|
2023
Q2 | $1.63M | Buy |
125,976
+40,637
| +48% | +$527K | ﹤0.01% | 3472 |
|
|
2023
Q1 | $1.08M | Buy |
+85,339
| New | +$1.08M | ﹤0.01% | 3515 |
|